Seroatlas · Human Serome Atlas

GP9

Platelet glycoprotein IX

Also known as: CD42a, GPIX, GPIX_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P14770
Gene
GP9
Ensembl
ENSG00000169704
Chromosome
3
Canonical length
177 aa
Protein class
CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins
Subcellular location
Nucleoplasm,Plasma membrane,Cytosol

OverviewNCBI Gene

This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency. [provided by RefSeq, Oct 2008]

Canonical amino-acid sequenceUniProt

177 residues, UniProt reviewed canonical sequence.

>P14770|GP9
     1  MPAWGALFLL WATAEATKDC PSPCTCRALE TMGLWVDCRG HGLTALPALP ARTRHLLLAN
    61  NSLQSVPPGA FDHLPQLQTL DVTQNPWHCD CSLTYLRLWL EDRTPEALLQ VRCASPSLAA
   121  HGPLGRLTGY QLGSCGWQLQ ASWVRPGVLW DVALVAVAAL GLALLAGLLC ATTEALD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GP9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.39
Highest tissue expression
8.8 nTPM

Expression across tissuesHPA

Tissue

  • spleen: 8.8 nTPM
  • bone marrow: 4.8 nTPM
  • lung: 3.2 nTPM
  • testis: 1.7 nTPM
  • choroid plexus: 0.6 nTPM
  • liver: 0.3 nTPM

Single-cell type

  • platelets: 3,990 nCPM
  • megakaryocytes: 952 nCPM
  • megakaryocyte progenitors: 108 nCPM
  • late spermatids: 30 nCPM
  • early spermatids: 18 nCPM
  • hofbauer cells: 3.4 nCPM

Immune cell

  • total PBMC: 52 nTPM
  • basophil: 29 nTPM
  • neutrophil: 14 nTPM
  • plasmacytoid DC: 3 nTPM
  • classical monocyte: 1.2 nTPM
  • intermediate monocyte: 0.7 nTPM

Brain region

  • choroid plexus: 1.3 nTPM
  • cerebral cortex: 0.8 nTPM
  • amygdala: 0.2 nTPM
  • cerebellum: 0.2 nTPM
  • hypothalamus: 0.2 nTPM
  • medulla oblongata: 0.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GP9.

Disease | AllUniProt

Conditions GP9 is implicated in, by any mechanism.

Disease | GeneticClinVar

29 pathogenic / likely-pathogenic of 169 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.46
gnomAD pLI
0.48
gnomAD missense Z
0.16
DepMap mean gene effect
-0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GP9 as an antibody target. Whether an autoantibody or antibody against GP9 could matter depends on whether native GP9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GP9 is annotated at the cell surface, where native GP9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GP9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GP9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...